CRYOPORT, INC. Stock-Based Compensation
CRYOPORT, INC. (CYRX) reported Stock-Based Compensation of $2.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- CRYOPORT, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.40M, a 17.46% increase year-over-year.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.40M, a 21.83% decline year-over-year.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.43M, a 33.29% decline year-over-year.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.53M, a 37.72% decline year-over-year.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $10.07M, a 39.24% decline from fiscal 2024.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $16.57M, a 16.43% decline from fiscal 2023.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $19.82M, a 1.29% decline from fiscal 2022.
- CRYOPORT, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $20.08M, a 30.87% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.40M 10-Q · filed 2026-08-06 | $4.80M 10-Q · filed 2026-08-06 | $7.23M derived: sum of 3 quarters · filed 2026-08-06 | $9.75M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.40M 10-Q · filed 2026-05-05 | $4.83M derived: sum of 2 quarters · filed 2026-05-05 | $7.35M derived: sum of 3 quarters · filed 2026-05-05 | $9.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.96M derived: sum of 2 quarters · filed 2026-03-05 | $7.00M derived: sum of 3 quarters · filed 2026-08-06 | $10.07M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $2.53M 10-Q · filed 2025-11-06 | $4.57M derived: sum of 2 quarters · filed 2026-08-06 | $7.63M 10-Q · filed 2025-11-06 | $11.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.04M 10-Q · filed 2026-08-06 | $5.11M 10-Q · filed 2026-08-06 | $8.75M derived: sum of 3 quarters · filed 2026-08-06 | $12.81M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.06M 10-Q · filed 2026-05-05 | $6.71M derived: sum of 2 quarters · filed 2026-05-05 | $10.76M derived: sum of 3 quarters · filed 2026-05-05 | $14.96M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.70M derived: sum of 2 quarters · filed 2026-03-05 | $11.90M derived: sum of 3 quarters · filed 2026-03-05 | $16.57M 10-K · filed 2026-03-05 | $19.70M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $4.06M 10-Q · filed 2025-11-06 | $4.84M 10-Q · filed 2024-11-07 | $8.26M derived: sum of 2 quarters · filed 2025-11-06 | $12.92M 10-Q · filed 2025-11-06 | $15.29M 10-Q · filed 2024-11-07 | $15.79M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-06-30 | $4.20M 10-Q · filed 2025-08-12 | $5.00M 10-Q · filed 2024-08-08 | $8.87M 10-Q · filed 2025-08-12 | $10.45M 10-Q · filed 2024-08-08 | $11.73M derived: sum of 3 quarters · filed 2026-03-05 | $17.71M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-03-31 | $4.67M 10-Q · filed 2025-05-08 | $5.46M 10-Q · filed 2024-05-08 | $7.53M derived: sum of 2 quarters · filed 2026-03-05 | $13.51M derived: sum of 3 quarters · filed 2026-03-05 | $19.30M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $8.84M derived: sum of 2 quarters · filed 2026-03-05 | $14.64M derived: sum of 3 quarters · filed 2026-03-05 | $19.82M 10-K · filed 2026-03-05 | $22.81M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $5.98M 10-Q · filed 2024-11-07 | $11.78M derived: sum of 2 quarters · filed 2024-11-07 | $16.96M 10-Q · filed 2024-11-07 | $22.29M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $5.80M 10-Q · filed 2024-08-08 | $10.98M 10-Q · filed 2024-08-08 | $16.32M derived: sum of 3 quarters · filed 2025-03-07 | $21.68M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $5.18M 10-Q · filed 2024-05-08 | $10.52M derived: sum of 2 quarters · filed 2025-03-07 | $15.88M derived: sum of 3 quarters · filed 2025-03-07 | $21.14M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $10.70M derived: sum of 2 quarters · filed 2025-03-07 | $15.96M derived: sum of 3 quarters · filed 2025-03-07 | $20.08M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $5.37M 10-Q · filed 2023-11-09 | $10.62M derived: sum of 2 quarters · filed 2023-11-09 | $14.75M 10-Q · filed 2023-11-09 | $18.93M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $5.26M 10-Q · filed 2023-08-09 | $9.38M 10-Q · filed 2023-08-09 | $13.56M derived: sum of 3 quarters · filed 2024-03-13 | $17.71M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $4.13M 10-Q · filed 2023-05-04 | $8.31M derived: sum of 2 quarters · filed 2024-03-13 | $12.46M derived: sum of 3 quarters · filed 2024-03-13 | $16.48M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $8.33M derived: sum of 2 quarters · filed 2024-03-13 | $12.35M derived: sum of 3 quarters · filed 2024-03-13 | $15.35M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $4.15M 10-Q · filed 2022-11-04 | $8.17M derived: sum of 2 quarters · filed 2022-11-04 | $11.16M 10-Q · filed 2022-11-04 | $13.72M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $4.02M 10-Q · filed 2022-08-04 | $7.01M 10-Q · filed 2022-08-04 | $9.57M derived: sum of 3 quarters · filed 2023-02-28 | $12.01M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $2.99M 10-Q · filed 2022-05-05 | $5.55M derived: sum of 2 quarters · filed 2023-02-28 | $7.98M derived: sum of 3 quarters · filed 2023-02-28 | $10.29M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.99M derived: sum of 2 quarters · filed 2023-02-28 | $7.29M derived: sum of 3 quarters · filed 2023-02-28 | $8.92M 10-K · filed 2023-02-28 | $8.92K 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $2.43M 10-Q · filed 2021-11-04 | $2.43M 10-Q · filed 2020-11-06 | $4.73M derived: sum of 2 quarters · filed 2021-11-04 | $6.36M 10-Q · filed 2021-11-04 | $6.35M 10-Q · filed 2020-11-06 | $6.74M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $2.30M 10-Q · filed 2021-08-06 | $2.30M 10-Q · filed 2020-08-10 | $3.92M 10-Q · filed 2021-08-06 | $3.92M 10-Q · filed 2020-08-10 | $4.30M derived: sum of 3 quarters · filed 2022-02-28 | $17.04M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $1.62M 10-Q · filed 2021-05-06 | $1.62M 10-Q · filed 2020-05-08 | $2.00M derived: sum of 2 quarters · filed 2022-02-28 | $14.74M derived: sum of 3 quarters · filed 2022-02-28 | $16.73M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $381.96K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $13.12M derived: sum of 2 quarters · filed 2022-02-28 | $15.11M derived: sum of 3 quarters · filed 2022-02-28 | $16.52M 10-K · filed 2022-02-28 | $16.52M 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $12.74M 10-Q · filed 2020-11-06 | $14.73M derived: sum of 2 quarters · filed 2020-11-06 | $16.14M 10-Q · filed 2020-11-06 | $17.63M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $1.99M 10-Q · filed 2020-08-10 | $3.41M 10-Q · filed 2020-08-10 | $4.89M derived: sum of 3 quarters · filed 2020-08-10 | $6.39M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $1.41M 10-Q · filed 2020-05-08 | $2.90M derived: sum of 2 quarters · filed 2020-05-08 | $4.40M derived: sum of 3 quarters · filed 2020-05-08 | $5.84M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.98M derived: sum of 2 quarters · filed 2020-03-10 | $4.43M derived: sum of 3 quarters · filed 2020-03-10 | $5.48M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $1.50M 10-Q · filed 2019-11-12 | $2.94M derived: sum of 2 quarters · filed 2019-11-12 | $3.99M 10-Q · filed 2019-11-12 | $5.01M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.44M 10-Q · filed 2019-08-09 | $1.45M 10-Q · filed 2018-08-09 | $2.50M 10-Q · filed 2019-08-09 | $3.51M derived: sum of 3 quarters · filed 2019-08-09 | $4.48M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $1.05M 10-Q · filed 2019-05-09 | $2.07M derived: sum of 2 quarters · filed 2019-05-09 | $3.03M derived: sum of 3 quarters · filed 2019-05-09 | $3.83M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.98M derived: sum of 2 quarters · filed 2019-03-13 | $2.78M derived: sum of 3 quarters · filed 2019-03-13 | $3.55M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $964.86K 10-Q · filed 2018-11-08 | $1.76M derived: sum of 2 quarters · filed 2018-11-08 | $2.53M 10-Q · filed 2018-11-08 | $3.31M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $794.56K 10-Q · filed 2018-08-09 | $1.57M 10-Q · filed 2018-08-09 | $2.35M derived: sum of 3 quarters · filed 2018-08-09 | $3.14M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $770.44K 10-Q · filed 2018-05-03 | $1.55M derived: sum of 2 quarters · filed 2018-05-03 | $2.35M derived: sum of 3 quarters · filed 2018-05-03 | $3.10M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $780.01K derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08 | $1.58M derived: sum of 2 quarters · filed 2018-03-08 | $2.33M 10-K · filed 2018-03-08 | $3.12M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $799.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $1.55M 10-Q · filed 2016-11-14 | $2.34M 10-Q · filed 2017-11-02 | $3.28M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-06-30 | $749.20K 10-Q · filed 2016-08-15 | $1.54M 10-Q · filed 2017-08-09 | $2.48M derived: sum of 3 quarters · filed 2017-05-04 | $3.11M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-03-31 | $788.94K 10-Q · filed 2017-05-04 | $1.73M derived: sum of 2 quarters · filed 2017-05-04 | $2.37M derived: sum of 3 quarters · filed 2017-05-04 | $2.88M 10-KT · filed 2017-03-13 | ||||
| 2015-12-31 | $939.22K derived: 10-KT 9 month − 10-Q 6 month · filed 2017-03-13 | $1.58M derived: sum of 2 quarters · filed 2017-03-13 | $2.06M 10-KT · filed 2017-03-13 | $2.37M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-09-30 | $637.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $1.12M 10-Q · filed 2016-11-14 | $1.43M derived: sum of 3 quarters · filed 2016-11-14 | $1.65M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $480.38K 10-Q · filed 2016-08-15 | $796.86K derived: sum of 2 quarters · filed 2016-08-15 | $1.01M derived: sum of 3 quarters · filed 2016-08-15 | $1.19M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $316.49K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28 | $527.25K derived: sum of 2 quarters · filed 2016-06-28 | $714.61K derived: sum of 3 quarters · filed 2016-06-28 | $881.71K 10-K · filed 2016-06-28 | ||||
| 2014-12-31 | $210.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-11 | $398.13K derived: sum of 2 quarters · filed 2016-02-11 | $565.22K 10-Q · filed 2016-02-11 | $733.37K derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-09-30 | $187.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | $354.45K 10-Q · filed 2015-11-16 | $522.61K derived: sum of 3 quarters · filed 2015-11-16 | $701.35K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $167.09K 10-Q · filed 2015-08-06 | $335.25K derived: sum of 2 quarters · filed 2015-08-06 | $513.99K derived: sum of 3 quarters · filed 2015-08-06 | $688.01K derived: sum of 4 quarters · filed 2015-08-06 | ||||
| 2014-03-31 | $168.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $346.90K derived: sum of 2 quarters · filed 2015-05-19 | $520.92K derived: sum of 3 quarters · filed 2015-05-19 | $678.12K 10-K · filed 2015-05-19 | ||||
| 2013-12-31 | $178.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $352.76K derived: sum of 2 quarters · filed 2015-02-05 | $509.97K 10-Q · filed 2015-02-05 | |||||
| 2013-09-30 | $174.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12 | $331.22K 10-Q · filed 2014-11-12 | ||||||
| 2013-06-30 | $157.20K 10-Q · filed 2014-07-31 | |||||||
| 2013-03-31 | $693.18K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |